Literature DB >> 23291209

Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample.

Adam R Winstock1, Monica J Barratt.   

Abstract

BACKGROUND: The last decade has seen the appearance of myriad novel psychoactive substances with diverse effect profiles. Synthetic cannabinoids are among the most recently identified but least researched of these substances.
METHODS: An anonymous online survey was conducted in 2011 using a quantitative structured research tool. Missing data (median 2%) were treated by available-case analysis.
RESULTS: Of 14,966 participants, 2513 (17%) reported use of synthetic cannabis. Of these, 980 (41% of 2417) reported its use in the last 12 months. Almost all recent synthetic cannabis users (99% of 975) reported ever use of natural cannabis. Synthetic cannabis reportedly had both a shorter duration of action (z=17.82, p<.001) and quicker time to peak onset of effect (z=-9.44, p<.001) than natural cannabis. Natural cannabis was preferred to synthetic cannabis by 93% of users, with natural cannabis rated as having greater pleasurable effects when high (t(930)=-37.1, p<.001, d=-1.22) and being more able to function after use (t(884)=-13.3, p<.001, d=-0.45). Synthetic cannabis was associated with more negative effects (t(859)=18.7, p<.001, d=0.64), hangover effects (t(854)=6.45, p<.001, d=0.22) and greater paranoia (t(889)=7.91, p<.001, d=0.27).
CONCLUSIONS: Users report a strong preference for natural over synthetic cannabis. The latter has a less desirable effect profile. Further research is required to determine longer term consequences of use and comparative dependence potential.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291209     DOI: 10.1016/j.drugalcdep.2012.12.011

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  62 in total

1.  Attitudes and Beliefs About New Psychoactive Substance Use Among Electronic Dance Music Party Attendees.

Authors:  Joseph J Palamar; Patricia Acosta; Charles M Cleland
Journal:  Subst Use Misuse       Date:  2017-08-04       Impact factor: 2.164

2.  Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature.

Authors:  Ayse Sinangil; Vedat Celik; Alev Kockar; Tevfik Ecder
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.

Authors:  Brian F Thomas; Timothy W Lefever; Ricardo A Cortes; Megan Grabenauer; Alexander L Kovach; Anderson O Cox; Purvi R Patel; Gerald T Pollard; Julie A Marusich; Richard C Kevin; Thomas F Gamage; Jenny L Wiley
Journal:  J Pharmacol Exp Ther       Date:  2017-01-13       Impact factor: 4.030

4.  Positive Allosteric Modulation of the 5-HT1A Receptor by Indole-Based Synthetic Cannabinoids Abused by Humans.

Authors:  Hideaki Yano; Pramisha Adhikari; Sett Naing; Alexander F Hoffman; Michael H Baumann; Carl R Lupica; Lei Shi
Journal:  ACS Chem Neurosci       Date:  2020-04-30       Impact factor: 4.418

Review 5.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

6.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

7.  Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.

Authors:  S Grassin-Delyle; E Naline; A Buenestado; C Faisy; J-C Alvarez; H Salvator; C Abrial; C Advenier; L Zemoura; P Devillier
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.

Authors:  Erin E Bonar; Lisham Ashrafioun; Mark A Ilgen
Journal:  Drug Alcohol Depend       Date:  2014-07-17       Impact factor: 4.492

9.  A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes.

Authors:  Claire E Blevins; Kelsey E Banes; Robert S Stephens; Denise D Walker; Roger A Roffman
Journal:  Addict Behav       Date:  2016-07-08       Impact factor: 3.913

10.  Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.

Authors:  Katherine M Keyes; Caroline Rutherford; Ava Hamilton; Joseph J Palamar
Journal:  Drug Alcohol Depend       Date:  2016-07-28       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.